Ligand Pharmaceuticals Incorporated
$121.24
24H
Market Cap
Volume
Supply
Price Chart
About Ligand Pharmaceuticals Incorporated - LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Their business model is based on revenue from partnerships, including license fees, milestone payments, and royalties on sales of drugs that are commercialized using their technologies.
What are Ligand Pharmaceuticals Incorporated's core values and mission statement?
Ligand Pharmaceuticals Incorporated's core values focus on innovation, collaboration, and commitment to patient health through the discovery and development of pioneering medicines. Their mission is to leverage their innovative drug discovery and development platform technologies to create and provide new medicines that improve patients' lives.
Who founded Ligand Pharmaceuticals Incorporated and when?
Ligand Pharmaceuticals Incorporated was founded in 1987 by David E. Robinson and Rodney Lappe.
Who leads Ligand Pharmaceuticals Incorporated?
As of my last update, John L. Higgins serves as the CEO of Ligand Pharmaceuticals Incorporated. Please note that corporate leadership can change, and you may want to check the most current information from official company sources.
Where is Ligand Pharmaceuticals Incorporated located, and what is its base country?
Ligand Pharmaceuticals Incorporated is headquartered in San Diego, California, USA, which is also its base country.
On which exchanges is Ligand Pharmaceuticals Incorporated traded?
Ligand Pharmaceuticals Incorporated is traded on the Nasdaq Stock Market under the ticker symbol LGND.
Historical data
Ligand Pharmaceuticals Incorporated (LGND) Price Live Data
The live price of Ligand Pharmaceuticals Incorporated (LGND) is $121.24, with a trading volume of 216,596 in the last 24 hours. Wrapstocks updates the LGND price in real-time. Ligand Pharmaceuticals Incorporated is down -6.67% in the last 24 hours. The company has a live market cap of $2,214,933,504.00 and a supply of 18,269,000 LGND stocks.
Ligand Pharmaceuticals Incorporated (LGND) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 6 hours and 9 minutes.
